Shuttle Pharmaceuticals Holdings (SHPH) Operating Leases (2021 - 2026)
Shuttle Pharmaceuticals Holdings' (SHPH) quarterly Operating Leases came in at $134051.0 in Q1 2026, down 39.1% year-on-year from $220110.0 in Q1 2025, and down 13.49% quarter-over-quarter from $154953.0 in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Operating Leases (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Operating Leases history runs 6 years deep, the most recent figure standing at $134051.0 for Q1 2026.
- On a quarterly basis, Operating Leases fell 39.1% year-over-year to $134051.0 in Q1 2026; TTM through Mar 2026 was $134051.0, a 39.1% decrease from a year earlier, with the FY2025 full-year figure at $154953.0, down 34.92% from the prior year.
- Operating Leases declined to $134051.0 in Q1 2026 per SHPH's latest filing, from $154953.0 in the prior quarter.
- Across five years, Operating Leases topped out at $343154.0 in Q1 2024 and bottomed at $44633.0 in Q1 2023.
- The 5-year median for Operating Leases is $238088.0 (2024), against an average of $220590.9.
- Across the five-year window, Operating Leases tumbled 51.44% in 2022 and jumped 668.83% in 2024, its largest moves.
- Year by year, Operating Leases stood at $62823.0 in 2022, then surged by 384.1% to $304127.0 in 2023, then fell by 21.71% to $238088.0 in 2024, then sank by 34.92% to $154953.0 in 2025, then fell by 13.49% to $134051.0 in 2026.
- Per Business Quant, the three latest SHPH Operating Leases figures stand at $134051.0 (Q1 2026), $154953.0 (Q4 2025), and $249815.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Shuttle Pharmaceuticals Holdings | 120,186.04 | 120,186.04 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 134,051.00 |
| Dec 31, 2025 | 154,953.00 |
| Sep 30, 2025 | 249,815.00 |
| Jun 30, 2025 | 195,159.00 |
| Mar 31, 2025 | 220,110.00 |
| Dec 31, 2024 | 238,088.00 |
| Sep 30, 2024 | 314,257.00 |
| Jun 30, 2024 | 329,117.00 |
| Mar 31, 2024 | 343,154.00 |
| Dec 31, 2023 | 304,127.00 |
| Sep 30, 2023 | 308,425.00 |
| Jun 30, 2023 | 329,774.00 |
| Mar 31, 2023 | 44,633.00 |
| Dec 31, 2022 | 62,823.00 |
| Sep 30, 2022 | 80,378.00 |
| Dec 31, 2021 | 129,376.00 |